I agree that this site is using cookies. You can find further informations here.
X
Papanastasiou, Philemon
17  results:
Search for persons X
?
1

Secukinumab in Pediatric Patients with Plaque Psoriasis: Po..:

Sticherling, Michael ; Nikkels, Arjen F. ; Hamza, Ashraf M....
American Journal of Clinical Dermatology.  24 (2023)  5 - p. 821-835 , 2023
Link: https://doi.org/10.1007/..
 
?
2

Long-term Safety of Secukinumab Over Five Years in Patients..:

Gottlieb, Alice B. ; Deodhar, Atul ; Mcinnes, Iain B....
Acta Dermato-Venereologica.  102 (2022)  - p. adv00698 , 2022
Link: https://doi.org/10.2340/..
 
?
3

Efficacy of Secukinumab Across Subgroups and Overall Safety..:

Magnolo, Nina ; Kingo, Külli ; Laquer, Vivian...
Pediatric Drugs.  24 (2022)  4 - p. 377-387 , 2022
Link: https://doi.org/10.1007/..
 
?
4

25482 Secukinumab efficacy and safety profile in pediatric ..:

Bodemer, Christine ; Kaszuba, Andrzej ; Kingo, Külli...
Journal of the American Academy of Dermatology.  85 (2021)  3 - p. AB59 , 2021
Link: https://doi.org/10.1016/..
 
?
5

14190 Treatment with secukinumab of severe plaque psoriasis..:

Kaszuba, Andrzej ; Papanastasiou, Philemon ; Keefe, Deborah...
Journal of the American Academy of Dermatology.  83 (2020)  6 - p. AB133 , 2020
Link: https://doi.org/10.1016/..
 
?
6

Effects of intravenous zoledronic acid plus subcutaneous te..:

Cosman, Felicia ; Eriksen, Erik Fink ; Recknor, Chris...
Journal of Bone and Mineral Research.  26 (2010)  3 - p. 503-511 , 2010
Link: https://doi.org/10.1002/..
 
?
7

Poster 43: Effect of Intravenous Zoledronic Acid on Lumbar ..:

Saag, Kenneth ; Devogelaer, Jean‐Pierre ; Mesenbrink, Peter...
PM&R.  1 (2009)  9S - p. , 2009
Link: https://doi.org/10.1016/..
 
?
8

Zoledronic acid and risedronate in the prevention and treat..:

Reid, David M ; Devogelaer, Jean-Pierre ; Saag, Kenneth...
The Lancet.  373 (2009)  9671 - p. 1253-1263 , 2009
Link: https://doi.org/10.1016/..
 
?
9

Poster 42: Effect of a Single Intravenous Infusion of Zoled..:

Saag, Kenneth ; Devogelaer, Jean‐Pierre ; Mesenbrink, Peter...
PM&R.  1 (2009)  9S - p. , 2009
Link: https://doi.org/10.1016/..
 
?
10

Preliminary evidence for a structural benefit of the new bi..:

Jarrett, Stephen J. ; Conaghan, Philip G. ; Sloan, Victor S....
Arthritis & Rheumatism.  54 (2006)  5 - p. 1410-1414 , 2006
Link: https://doi.org/10.1002/..
 
?
11

Primary structure and biochemical properties of a variant-s..:

Papanastasiou, Philemon ; Bruderer, Thomas ; Li, Yajie..
Molecular and Biochemical Parasitology.  86 (1997)  1 - p. 13-27 , 1997
Link: https://doi.org/10.1016/..
 
?
12

The Release of the Variant Surface Protein of Giardia to It..:

Papanastasiou, Philemon ; Hiltpold, André ; Bommeli, Cordelia.
Biochemistry.  35 (1996)  31 - p. 10143-10148 , 1996
Link: https://doi.org/10.1021/..
 
?
13

Secukinumab in Pediatric Patients with Plaque Psoriasis: Po..:

Sticherling, Michael ; Nikkels, Arjen F ; Hamza, Ashraf M...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10460311/.  , 2023
Link: http://www.ncbi.nlm.nih...
 
?
14

Long-term safety of secukinumab over five years in patients..:

Gottlieb, Alice B ; Deodhar, Atul ; Mcinnes, Iain B...
https://eprints.gla.ac.uk/266351/1/266351.pdf.  , 2022
Link: https://eprints.gla.ac.u..
 
?
15

Efficacy of Secukinumab Across Subgroups and Overall Safety..:

Magnolo, Nina ; Kingo, Külli ; Laquer, Vivian...
http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9205811/.  , 2022
Link: http://www.ncbi.nlm.nih...
 
1-15